Concepedia

Margaret Peykamian

MP

Statistics

Publications

5

Citations

568

H-Index

5

Active since

1997

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Cleveland Clinic

GlaxoSmithKline (United Kingdom)

Margaret Peykamian is an author at Research Triangle Park Foundation specializing in pharmacology, headache disorders, and migraine pharmacotherapy.

Publications per year

1997–2015

5

Publications

5

A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents

Paul Winner, A. David Rothner, Joel R. Saper et al. · PEDIATRICS · 2000 · 281 citations

, , +17

Naratriptan is effective and well tolerated in the acute treatment of migraine

Ninan T. Mathew, Mahnaz Asgharnejad, Margaret Peykamian et al. · Neurology · 1997 · 133 citations

, , +13

A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy

L. Fredrik Jarskog, Martin T. Lowy, Richard Grove et al. · Schizophrenia Research · 2015 · 66 citations

, , +16

One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study

A. David Rothner, Paul Winner, Robert Nett et al. · Clinical Therapeutics · 2000 · 59 citations

, , +16

Sumatriptan‐Naproxen and Butalbital: A Double‐Blind, Placebo‐Controlled Crossover Study

Frederick J. Derosier, Fred D. Sheftell, Stephen D. Silberstein et al. · Headache The Journal of Head and Face Pain · 2011 · 29 citations

, , +11

1–5 of 5